Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis

Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis

Background and Aim. Antituberculosis (anti-TB) drug-induced liver injury (ATLI) is a common and serious adverse drug reaction of tuberculosis treatment, and the incidence of ATLI has been reported to vary from 2.0% to 28.0%. This study aims to estimate the incidence of ATLI in patients who receive a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nannan Wang, Xinyu Chen, Zhuolu Hao, Jia Guo, Xuwen Wang, Xijing Zhu, Honggang Yi, Qingliang Wang, Shaowen Tang
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Journal of Tropical Medicine
Online Access:	http://dx.doi.org/10.1155/2022/8266878
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic Polymorphisms of UDP-Glucuronosyltransferases and Susceptibility to Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis
by: Xinyu Chen, et al.
Published: (2023-01-01)

Liver Injury Associated with Antituberculosis Medications
by: Syifa Mustika, et al.
Published: (2025-07-01)

Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Study of the pharmacokinetics of antituberculosis drug Biomairin
by: Sh. A. Shomurotov, et al.
Published: (2018-11-01)

Effect of Traditional Chinese Medicine on antituberculosis drug therapy for pulmonary tuberculosis and liver function
by: Qing Huang, et al.
Published: (2025-04-01)

Seizures following Intoxication with a Common Antituberculosis Drug
by: Adnane Lahlou, et al.
Published: (2019-01-01)

Incidence, Clinical Features, Associated Factors and Outcomes of Intensive Phase Antituberculosis Drug Induced Liver Injury Among Patients With Tuberculosis at a Tertiary Care Hospital in Nepal: A Descriptive Cross‐Sectional Study
by: Ravi Ranjan Pradhan, et al.
Published: (2025-04-01)

Apoptosis-Inducing Action of Antituberculosis Drugs of the Main Group in Vitro
by: O. A. Vasilyeva, et al.
Published: (2020-05-01)

ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT
by: M. E. Kim, et al.
Published: (2016-09-01)

Rifapex, a New Antituberculosis Agent
by: G. B. Sokolova, et al.
Published: (2020-05-01)

Empyema Necessitans due to Interruption of Antituberculosis Treatment
by: H. N. Benaragama, et al.
Published: (2019-01-01)

Spherical amorphous nanoparticles loading with antituberculosis substance rifabutin
by: A. P. Kaplun, et al.
Published: (2010-04-01)

Synthesis of (±)-Pisonivanone and Other Analogs as Potent Antituberculosis Agents
by: A. Vasu Babu, et al.
Published: (2013-01-01)

Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.
by: Dominique J Pepper, et al.
Published: (2011-05-01)

Drug-induced liver injuries
by: S. F. Galimova
Published: (2014-07-01)

Quality of life features in patients on the second-line antituberculosis therapy
by: T. V. Pyanzova, et al.
Published: (2012-08-01)

TIPdb: A Database of Anticancer, Antiplatelet, and Antituberculosis Phytochemicals from Indigenous Plants in Taiwan
by: Ying-Chi Lin, et al.
Published: (2013-01-01)

Analysis and prediction of the incidence temporal trends of echinococcosis in China from 2010 to 2021
by: Jiajia Ai, et al.
Published: (2025-02-01)

Causes and Management of Chest Computed Tomography Lesions Progression in Pulmonary Tuberculosis during Antituberculosis Treatment
by: Shuangyin Yang, et al.
Published: (2025-04-01)

Temporal trends and future projections of incidence rate and mortality for asthma in China: an analysis of the Global Burden of Disease Study 2021
by: Xi Chen, et al.
Published: (2025-01-01)

Liver cancer incidence in Saudi Arabia (2001–2020): decreasing trend
by: Nasr Eldin Elwali, et al.
Published: (2025-08-01)

Spatial heterogeneity and temporal trends of thyroid cancer incidence in Iran from 2014 to 2017
by: Mohsen Soleimani, et al.
Published: (2025-07-01)

Synthesis and Characterization of Nanohydroxyapatite-Gelatin Composite with Streptomycin as Antituberculosis Injectable Bone Substitute
by: Dyah Hikmawati, et al.
Published: (2019-01-01)

Indirect patient expenses for antituberculosis treatment in Tijuana, Mexico: is treatment really free?
by: Gema Yolanda Guzmán-Montes, et al.
Published: (2009-11-01)

Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination.
by: Valerie A C M Koeken, et al.
Published: (2022-09-01)

Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.
by: Chloe I Bloom, et al.
Published: (2012-01-01)

Drug-induced liver injury in cancer patients
by: V. T. Ivashkin, et al.
Published: (2020-10-01)

Drug-induced liver injuries (part I)
by: S. F. Galimova
Published: (2018-08-01)

Drug-induced liver injuries (Part 1)
by: S. F. Galimova
Published: (2012-06-01)

Polymorphism of genes and drug-induced liver injury
by: P. Ye. Tkachenko, et al.
Published: (2013-09-01)

Antituberculosis activity of some 3,6-disubstituted 1,2,4,5-tetrazines
by: Rashida I. Ishmetova, et al.
Published: (2024-11-01)

Drug-induced liver injuries in pregnancy in the context of polypragmasy
by: N. Yu. Velts, et al.
Published: (2018-02-01)

Vanishing bile duct syndrome in drug-induced liver injury: clinical and pathologic perspectives
by: Sugunah Sallapan, et al.
Published: (2025-04-01)

Chinese Traditional Medicine NiuBeiXiaoHe (NBXH) Extracts Have the Function of Antituberculosis and Immune Recovery in BALB/c Mice
by: Yan Liang, et al.
Published: (2021-01-01)

Temporal trends in the incidence and outcomes of cardiopulmonary arrest events treated in the emergency department at a tertiary hospital in Jordan
by: Ahmad Alrawashdeh, et al.
Published: (2025-03-01)

Drug Induced Liver Injury Attributed to a Curcumin Supplement
by: Zaid Imam, et al.
Published: (2019-01-01)

A Case of Drug-Induced Liver Injury Secondary to Ceftriaxone
by: Rupesh Ramtel
Published: (2025-06-01)

A Case of Drug-Induced Liver Injury Secondary to Natalizumab
by: Phillip P. Santoiemma, et al.
Published: (2020-01-01)

Joint Decision-Making Model Based on Consensus Modeling Technology for the Prediction of Drug-Induced Liver Injury
by: Yukun Wang, et al.
Published: (2021-01-01)

Semaglutide‐Induced Hepatic Injury: A Rare Case of Drug Induced Liver Injury
by: Rupayan Kundu, et al.
Published: (2025-08-01)